Presentation is loading. Please wait.

Presentation is loading. Please wait.

Magnesium Sulfate • Perinatal Neuroprophylaxis

Similar presentations


Presentation on theme: "Magnesium Sulfate • Perinatal Neuroprophylaxis"— Presentation transcript:

1 Magnesium Sulfate • Perinatal Neuroprophylaxis
Preeclampsia Update 2006 11/13/2018 Magnesium Sulfate • Perinatal Neuroprophylaxis Thomas R. Easterling, MD Professor Maternal-Fetal Medicine University of Washington Seattle, WA

2 Preeclampsia Update 2006 11/13/2018

3 Preeclampsia Update 2006 11/13/2018

4 Preeclampsia Update 2006 11/13/2018 Long Term Survival

5 Impaired Work Capacity
Preeclampsia Update 2006 11/13/2018 Cerebral Palsy Term Rate Impaired Work Capacity Term Rate

6 Preeclampsia Update 2006 11/13/2018 Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial Lancet, 1995;345

7 Antenatal Steroids Reduce the Incidence Of Cerebral Palsy
Preeclampsia Update 2006 11/13/2018 Cerebral Palsy All trials 6.4% vs. 10.2% OR 0.59 ( ) Antenatal Steroids Reduce the Incidence Of Cerebral Palsy

8 • < 30 weeks’ Gestation • MgSO4 - 4 g Bolus - 1 g per Hour
Preeclampsia Update 2006 11/13/2018 • < 30 weeks’ Gestation • MgSO g Bolus - 1 g per Hour • 2 Year Follow-up

9 Preeclampsia Update 2006 11/13/2018

10 Preeclampsia Update 2006 11/13/2018

11 • < 24-31 weeks’ Gestation • MgSO4 - 4 g Bolus - 2 g per Hour
Preeclampsia Update 2006 11/13/2018 • < weeks’ Gestation • MgSO g Bolus - 2 g per Hour • 2 Year Follow-up

12 Preeclampsia Update 2006 11/13/2018

13

14

15

16

17 Preeclampsia Update 2006 11/13/2018

18 • < 33 weeks’ Gestation • MgSO4 - 4 g Bolus - no maintenance
Preeclampsia Update 2006 11/13/2018 • < 33 weeks’ Gestation • MgSO g Bolus - no maintenance • At Hospital Discharge

19 WMI - white matter injury
Preeclampsia Update 2006 11/13/2018 WMI - white matter injury

20 • 5 Clinical Trial with 6145 Babies
• Cerebral Palsy (RR) 0.68 CI (0.54 to 0.87) • Gross Motor Dysfunction (RR) 0.61 CI (0.44 to 0.85) “The neuroprotective role for antenatal magnesium sulfate … is now established.” The number of women to treat to benefit one baby is 63; 95% CI (43 to 155).

21

22 Cerebral Palsy

23 Gross Motor Dysfunction

24 Pediatric Mortality

25 Preeclampsia Update 2006 11/13/2018

26 Preeclampsia Update 2006 11/13/2018

27 Preeclampsia Update 2006 11/13/2018 1 1 2 2 3 3

28 Preeclampsia Update 2006 11/13/2018

29 Mg++ Neuroprophylaxis Mechanism NMDA - (N-methyl-D-aspartate)
Preeclampsia Update 2006 11/13/2018 Mg++ Neuroprophylaxis Mechanism CNS NMDA - (N-methyl-D-aspartate) Hypoxia • activation of NMDA and non-NMDA receptors by the excitatory neurotransmitter, glutamine • increased intracellular Ca++ • intracellular Ca++ - free radical generation and cell death

30 Preeclampsia Update 2006 11/13/2018

31 Mg++ Neuroprophylaxis Mechanism Microvascular Stabilization
Preeclampsia Update 2006 11/13/2018 Mg++ Neuroprophylaxis Mechanism non-CNS Microvascular Stabilization Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial Lancet, 1995;345

32 Magnesium Sulfate for Neuroprotection Final Recommendations - draft
Preeclampsia Update 2006 11/13/2018 Magnesium Sulfate for Neuroprotection Final Recommendations - draft • Indication Imminent preterm delivery Not limited by cause of risk (eg. PROM, PTL, preeclampsia, bleeding…) • Gestational Age < 28 weeks gestation – recommended 28-34 weeks gestation - offered with counseling • Dose 4 gm bolus, followed by 1gm/hour infusion. Mg levels not indicated without renal complications. • Discontinuation undelivered in 12 hours • Restart recurrent risk for preterm delivery >3 hours from d/c - rebolus • Urgent delivery should not be delayed to wait for MgSO4

33 Impaired Work Capacity
Preeclampsia Update 2006 11/13/2018 Cerebral Palsy Term Rate Impaired Work Capacity Term Rate

34 Magnesium Sulfate for Neuroprotection Final Recommendations - draft
Preeclampsia Update 2006 11/13/2018 Magnesium Sulfate for Neuroprotection Final Recommendations - draft • Indication Imminent preterm delivery Not limited by cause of risk (eg. PROM, PTL, preeclampsia, bleeding…) • Gestational Age < 28 weeks gestation – recommended 28-34 weeks gestation - offered with counseling • Dose 4 gm bolus, followed by 1gm/hour infusion. Mg levels not indicated without renal complications. • Discontinuation undelivered in 12 hours • Restart recurrent risk for preterm delivery >3 hours from d/c - rebolus • Urgent delivery should not be delayed to wait for MgSO4


Download ppt "Magnesium Sulfate • Perinatal Neuroprophylaxis"

Similar presentations


Ads by Google